HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 92 filers reported holding HARVARD BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,876,929 | -17.6% | 2,064,402 | +5.2% | 0.00% | – |
| Q2 2023 | $10,771,474 | +47.1% | 1,962,017 | +12.5% | 0.00% | – |
| Q1 2023 | $7,324,783 | +110.2% | 1,743,996 | +38.7% | 0.00% | – |
| Q4 2022 | $3,484,100 | -11.5% | 1,257,798 | -18.2% | 0.00% | – |
| Q3 2022 | $3,938,000 | -28.9% | 1,538,283 | 0.0% | 0.00% | – |
| Q2 2022 | $5,538,000 | -53.7% | 1,538,283 | -20.1% | 0.00% | – |
| Q1 2022 | $11,952,000 | -0.6% | 1,924,517 | +12.8% | 0.00% | – |
| Q4 2021 | $12,025,000 | -4.4% | 1,705,685 | -5.3% | 0.00% | – |
| Q3 2021 | $12,576,000 | -21.6% | 1,801,705 | -6.4% | 0.00% | – |
| Q2 2021 | $16,043,000 | +92.9% | 1,925,868 | +26.4% | 0.00% | – |
| Q1 2021 | $8,318,000 | +5.7% | 1,523,327 | -16.9% | 0.00% | – |
| Q4 2020 | $7,866,000 | +29.0% | 1,833,716 | -9.5% | 0.00% | – |
| Q3 2020 | $6,099,000 | -8.4% | 2,026,097 | -5.6% | 0.00% | – |
| Q2 2020 | $6,657,000 | +50.4% | 2,147,269 | +7.2% | 0.00% | – |
| Q1 2020 | $4,426,000 | -0.7% | 2,002,899 | +37.1% | 0.00% | – |
| Q4 2019 | $4,457,000 | +10.1% | 1,461,199 | +11.0% | 0.00% | – |
| Q3 2019 | $4,049,000 | +13.0% | 1,316,599 | -26.5% | 0.00% | – |
| Q2 2019 | $3,584,000 | -54.7% | 1,791,842 | -2.4% | 0.00% | – |
| Q1 2019 | $7,916,000 | +35.2% | 1,836,648 | -0.3% | 0.00% | – |
| Q4 2018 | $5,857,000 | -38.4% | 1,841,800 | +1.6% | 0.00% | – |
| Q3 2018 | $9,515,000 | +14.2% | 1,812,401 | +16.3% | 0.00% | – |
| Q2 2018 | $8,334,000 | +22.3% | 1,557,908 | +14.3% | 0.00% | – |
| Q1 2018 | $6,817,000 | +33.9% | 1,363,406 | -11.6% | 0.00% | – |
| Q4 2017 | $5,090,000 | -13.7% | 1,542,534 | -1.9% | 0.00% | – |
| Q3 2017 | $5,899,000 | +50.2% | 1,573,069 | +2.1% | 0.00% | – |
| Q2 2017 | $3,927,000 | -0.3% | 1,540,021 | +1.7% | 0.00% | – |
| Q1 2017 | $3,937,000 | -13.5% | 1,514,439 | +1.5% | 0.00% | – |
| Q4 2016 | $4,550,000 | +12.4% | 1,491,999 | +0.3% | 0.00% | – |
| Q3 2016 | $4,047,000 | -1.0% | 1,488,123 | +4.1% | 0.00% | – |
| Q2 2016 | $4,087,000 | -8.9% | 1,428,910 | -3.8% | 0.00% | – |
| Q1 2016 | $4,486,000 | -9.8% | 1,485,453 | +3.6% | 0.00% | – |
| Q4 2015 | $4,975,000 | -96.5% | 1,433,804 | -77.9% | 0.00% | -100.0% |
| Q3 2015 | $142,421,000 | +2153.1% | 6,491,476 | +485.3% | 0.01% | – |
| Q2 2015 | $6,321,000 | +3.0% | 1,109,041 | +5.2% | 0.00% | – |
| Q1 2015 | $6,134,000 | +5.8% | 1,053,930 | +3.1% | 0.00% | – |
| Q4 2014 | $5,795,000 | +42.0% | 1,021,950 | +2.5% | 0.00% | – |
| Q3 2014 | $4,080,000 | -1.6% | 997,425 | +9.5% | 0.00% | – |
| Q2 2014 | $4,145,000 | -6.0% | 911,084 | -2.0% | 0.00% | – |
| Q1 2014 | $4,408,000 | +5.3% | 929,823 | +4.4% | 0.00% | – |
| Q4 2013 | $4,187,000 | -7.1% | 890,852 | +3.9% | 0.00% | – |
| Q3 2013 | $4,509,000 | +13.2% | 857,214 | +1.8% | 0.00% | – |
| Q2 2013 | $3,984,000 | – | 842,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |